An implant device release agent and its directions - ENDO PHARMACEUTICALS SOLUTIONS INC.

Title:

An implant device release agent and its directions

Document Type and Number:

Japanese Patent JP5947430

Kind Code:

B2

Abstract:

Medical implant devices are prepared from a polymeric material and a release agent, where the device is a molded, reservoir implant, and the release agent has a molecular weight (MW) of at least 1000. The release agent may be a non-ionic surfactant such as Brij 35, polyoxyetheylene(20)sorbitan trioleate, Tween 20, Tween 80, vitamin E TPGS, and a mixture of any two or more thereof. Hydrated implants may have a surface area of about 500 mm2 or greater.

More Like This:

WO/2004/093807	SOMATOSTATIN VECTORS
JPH082798	INDUSTRIAL APPLICABILITY A new type of analgesic using an antibody.
JP2008505849	Inhibitors of serine proteases, especially HCV and NS3-NS4A proteases

Inventors:

Hvant
Decker, Stephanie
Kuzuma, Petr

Application Number:

JP2015158227A

Publication Date:

July 06, 2016

Filing Date:

August 10, 2015

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ENDO PHARMACEUTICALS SOLUTIONS INC.

International Classes:

A61K38/04; A61K9/00; A61K47/14; A61K47/22; A61K47/32; A61K47/34; A61P5/02; A61P43/00

Domestic Patent References:

JP2002535452A
JP5269759A
JP5269760A

Foreign References:

WO2006099288A1

Attorney, Agent or Firm:

Moriaki Ogawa
Shoichi Okuyama
Haruyuki Nishiyama
Mitsuji Sekiya
Arihara Koichi
Matsushima Tetsuo
Hidefumi Kawamura

Previous Patent: An auxiliary member for shoehorns used attaching to a Kutsukakato part

Next Patent: APPARATUS FOR TREATING RESIDUAL TAIL YARN OF SPINDLE OF SPINNING MACHINE